National Health Investors, Inc. $NHI Shares Purchased by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management GmbH has significantly increased its stake in National Health Investors, Inc. by 111.9% during the 2nd quarter, owning 120,625 shares valued at approximately $8.5 million.
• Analysts have set new price targets for NHI, with Wells Fargo raising it to $80.00, and National Bankshares setting a target of $90.00, reflecting positive outlooks for the company.
• National Health Investors announced a quarterly dividend increase to $0.92 per share, marking a 2.2% rise from the previous dividend, with an annualized yield of 4.9%.

Allianz Asset Management GmbH increased its stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 111.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 120,625 shares of the real estate investment trust's stock after purchasing an additional 63,697 shares during the period. Allianz Asset Management GmbH owned 0.26% of National Health Investors worth $8,458,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of NHI. Smartleaf Asset Management LLC raised its position in shares of National Health Investors by 49.8% during the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust's stock worth $33,000 after purchasing an additional 147 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock worth $114,000 after purchasing an additional 345 shares during the last quarter. Jupiter Asset Management Ltd. acquired a new position in shares of National Health Investors during the 1st quarter worth about $206,000. Xponance Inc. raised its position in shares of National Health Investors by 11.2% during the 1st quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust's stock worth $246,000 after purchasing an additional 337 shares during the last quarter. Finally, Monument Capital Management acquired a new position in shares of National Health Investors during the 2nd quarter worth about $252,000. Institutional investors and hedge funds own 62.51% of the company's stock.

Analysts Set New Price Targets

NHI has been the subject of a number of recent research reports. Wells Fargo & Company increased their price objective on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday, August 27th. National Bankshares set a $90.00 price objective on shares of National Health Investors in a report on Wednesday, October 1st. Truist Financial increased their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a report on Friday, August 15th. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Finally, Weiss Ratings reiterated a "buy (b-)" rating on shares of National Health Investors in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $84.83.

National Health Investors Stock Down 1.7%

Shares of NYSE NHI opened at $74.77 on Wednesday. The company has a 50 day simple moving average of $77.07 and a 200-day simple moving average of $74.13. The company has a market capitalization of $3.55 billion, a P/E ratio of 23.89, a P/E/G ratio of 3.44 and a beta of 0.77. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. National Health Investors, Inc. has a 1 year low of $65.13 and a 1 year high of $82.32.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.16 by $0.06. The business had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The business's revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.18 EPS. On average, equities research analysts predict that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.9%. This is an increase from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's payout ratio is 117.57%.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.